What treatment strategies are used in relapsed acute myeloid leukemia?

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Curtis Lachowiez, MD Anderson Cancer Center, Houston, US, about treatment strategies used in relapsed acute myeloid leukemia. Lachowiez underlines the importance of using genetic information and the patient's condition to help guide treatment.

All content on Know AML is primarily intended for patients and caregivers. If you are a healthcare professional, please visit the AML Hub.

Please get in touch if you have any questions about Know AML or if you would like to discuss a potential collaboration.

Brought to you by

Scientific Education Support

In collaboration with

Thank you to the funders of Know AML. All content is developed independently by SES in collaboration with an expert ambassador group; funders are allowed no influence on the content of Know AML.

v2.29.00